What is the success rate of PDA treatment?

High Success Rates in Transcatheter PDA Closure with ADO I

Patent ductus arteriosus (PDA), a congenital heart defect where a fetal blood vessel fails to close after birth, is commonly treated through transcatheter closure. Recent data highlights the effectiveness of this minimally invasive approach, particularly when using the Amplatzer Duct Occluder I (ADO I). In a recent study, the success rate of PDA closure using ADO I reached an impressive 95.3%, reinforcing its reputation as a reliable treatment option.

While the procedure is generally safe and efficient, complications can occur. One of the most significant risks is device embolization—when the occluder detaches and moves from its intended position. This typically happens during the release phase and most often results in the device traveling into the pulmonary artery. In rarer cases, it may enter the systemic circulation, requiring prompt intervention. Despite these risks, the high success rate and low complication profile make ADO I a preferred choice for many interventional cardiologists.

Factors contributing to successful outcomes include proper patient selection, accurate device sizing, and operator experience. Advances in imaging techniques, such as echocardiography and angiography, have also improved procedural precision, reducing the likelihood of complications. For patients—especially children and young adults—this means a quicker recovery, shorter hospital stays, and fewer long-term issues compared to surgical ligation.

As technology and techniques continue to evolve, transcatheter PDA closure is becoming even safer and more accessible. With ongoing research and real-world clinical experience, the procedure's success rates are likely to improve further, offering hope and better quality of life for patients with PDA.